Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
FiercePharma
5h
J&J, Legend solidify Carvykti's lead in earlier multiple myeloma with strong survival showing
After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson ...
BioSpace
6h
J&J Posts Positive Phase III Results for Carvykti and Darzalex Faspro in Multiple Myeloma Trials
Johnson & Johnson linked Carvykti to a 45% reduction in risk of death and Darzalex to a 61% improvement in minimal residual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
NBA Hall of Famer dies
‘Ring of fire’ eclipse in Oct
Helene wreaks havoc
Trump's Erie rally
Illegal cloning sentencing
Blocks songs from artists
Grammy-winning singer dies
NYC tunnel shutdown
Harris' Las Vegas rally
To receive FEMA briefing
Mich. nuclear plant to restart
US wins Presidents Cup
Crew-9 astronauts at ISS
To sue Google, Samsung
Line Fire prompts evacuation
Firefighters injured in crash
Oil prices climb
Ozzie Virgil Sr. dies at 92
Three PFLP leaders killed
Defensive Player of the Year
$567M Taiwan defense aid
Newsom vetoes AI safety bill
Sells stake in DirecTV
Israeli forces launch raids
37 militants killed in Syria
US port strike looms
Seeks bribery dismissal
Nepal floods: Death toll rises
Related topics
Bristol-Myers Squibb
2seventy bio
newly diagnosed multiple myeloma
Feedback